Heart Drug Memantine Cuts Dangerous Irregular Heartbeats by Nearly Half
Clinical trial shows memantine reduces premature atrial contractions by 47% and prevents atrial fibrillation in heart patients.
433 articles in this topic
Clinical trial shows memantine reduces premature atrial contractions by 47% and prevents atrial fibrillation in heart patients.
New research reveals how tiny heart vessels automatically adjust to maintain blood flow when major arteries are blocked.
New research reveals how lifestyle choices and hereditary factors contribute to atrial fibrillation in younger people without heart disease.
Researchers discover that how atrial fibrillation episodes cluster together matters more for stroke risk than total time spent in irregular rhythm.
Standardized approach improves diagnosis and treatment of tricuspid regurgitation, a common heart valve problem linked to poor outcomes.
New genetic approach could revolutionize how we develop heart medications, potentially saving billions in failed drug trials.
New mapping technology identifies dangerous heart rhythm patterns that develop after surgical repair of heart defects.
Explore how the inner lining of blood vessels changes with age and impacts cardiovascular health and longevity.
Discover breathing techniques that lower blood pressure and adaptive medicine strategies for optimizing health naturally.
New research shows shingles vaccination dramatically reduces heart attacks, strokes, and death in people with existing heart disease.
Experimental drug enlicitide matches injectable therapies' power but in convenient pill form, potentially transforming heart disease prevention.
Mount Sinai study reveals widely-used cardiac screening tools fail to identify nearly 50% of people who will have heart attacks.